11 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
packaging must be selected and tested, and stability studies must be conducted to demonstrate that the biological product candidate does not undergo … , will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging, storage, distribution, import, export, advertising, promotion, sampling
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
for manufacturing, labeling, packaging, storage, distribution, import, export, advertising, promotion, sampling, recordkeeping and submission of safety and other … product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the biological
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
product candidates that may be approved in the U.S. in the future, will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging … methods for testing the identity, strength, quality, potency, and purity of the final biological product. Additionally, appropriate packaging must
S-1
z4tzp
29 Jun 23
IPO registration
4:39pm
DRS/A
zgb0heq81fz
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
3i4692by
2 May 23
Draft registration statement (amended)
12:00am
DRS
n5705xvm
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next